Published in Hypertension on January 29, 2007
Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. Am J Hypertens (2012) 2.02
Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med (2008) 2.00
Blood pressure dipping and sleep disturbance in African-American and Caucasian men and women. Am J Hypertens (2008) 1.92
A novel approach to office blood pressure measurement: 30-minute office blood pressure vs daytime ambulatory blood pressure. Ann Fam Med (2011) 1.19
The effect of measuring ambulatory blood pressure on nighttime sleep and daytime activity--implications for dipping. Clin J Am Soc Nephrol (2009) 0.98
Physical activity and hemodynamic reactivity in chronic kidney disease. Clin J Am Soc Nephrol (2008) 0.97
Can nocturnal hypertension predict cardiovascular risk? Integr Blood Press Control (2009) 0.96
Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Semin Nephrol (2007) 0.93
Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome. J Hypertens (2008) 0.90
Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the Recommended Amount of Sleep for a Healthy Adult: Methodology and Discussion. J Clin Sleep Med (2015) 0.87
Nighttime hospital blood pressure--a predictor of death, ESRD, and decline in GFR. Ren Fail (2010) 0.87
Comparison of Blood Pressure Control and Left Ventricular Hypertrophy in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Electrolyte Blood Press (2011) 0.83
Low life purpose and high hostility are related to an attenuated decline in nocturnal blood pressure. Health Psychol (2010) 0.82
Sleepers versus nonsleepers: another twist to the dipper/nondipper concept. Hypertension (2007) 0.79
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit (2015) 0.78
Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure. Nutrients (2016) 0.75
Comparison of the average of five readings with averages from fewer readings for automated oscillometric blood pressure measurement in an outpatient clinic. Korean Circ J (2013) 0.75
Why is nondipping in ambulatory blood pressure monitoring not prognostic in poor sleepers? Hypertension (2007) 0.75
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (2009) 6.25
Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension (2012) 5.60
Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension (2004) 4.38
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens (2011) 3.50
Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension (2005) 2.54
Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol (2006) 2.02
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am J Hypertens (2007) 1.97
Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension. J Hypertens (2004) 1.56
Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. Am J Hypertens (2004) 1.54
Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. Am J Hypertens (2006) 1.51
Do angiotensin II receptor blockers increase the risk of myocardial infarction? Eur Heart J (2005) 1.47
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J (2009) 1.47
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension. Am J Cardiol (2004) 1.42
Atrial fibrillation in hypertension: predictors and outcome. Hypertension (2003) 1.40
Blood pressure lowering in the oldest old. J Hypertens (2010) 1.40
Multivariable analysis in cerebrovascular research: practical notes for the clinician. Cerebrovasc Dis (2013) 1.38
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. J Hypertens (2009) 1.38
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens (2003) 1.16
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. Hypertension (2009) 1.16
Masked hypertension: evaluation, prognosis, and treatment. Am J Hypertens (2010) 1.12
Ambulatory blood pressure for cardiovascular risk stratification. Circulation (2007) 1.10
Clinical usefulness of ambulatory blood pressure monitoring. J Am Soc Nephrol (2004) 1.08
Contribution of the ABP-International study to the definition of night-time tachycardia. J Hypertens (2014) 1.07
Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04
Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials. J Hypertens (2010) 0.98
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. J Hypertens (2008) 0.97
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol (2002) 0.97
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? Curr Opin Cardiol (2007) 0.96
Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J Hypertens (2014) 0.96
Comparative assessment of angiotensin receptor blockers in different clinical settings. Vasc Health Risk Manag (2009) 0.94
[The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the weapons are ready]. Rev Esp Cardiol (2003) 0.93
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag (2009) 0.90
Improved cardiovascular risk stratification by a simple ECG index in hypertension. Am J Hypertens (2003) 0.90
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vasc Health Risk Manag (2008) 0.90
Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension. J Hypertens (2002) 0.90
New-onset diabetes, antihypertensive treatment, and outcome. Hypertension (2007) 0.90
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. Blood Press Monit (2004) 0.89
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. Curr Cardiol Rep (2012) 0.88
Aliskiren versus ramipril in hypertension. Ther Adv Cardiovasc Dis (2010) 0.88
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep (2012) 0.87
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. Eur J Endocrinol (2003) 0.87
Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study. Int J Cardiol (2013) 0.86
White-coat hypertension in adults. Blood Press Monit (2005) 0.86
Telmisartan for the reduction of cardiovascular morbidity and mortality. Expert Rev Clin Pharmacol (2011) 0.85
Is the definition of daytime and nighttime blood pressure prognostically relevant? Blood Press Monit (2008) 0.85
New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. Curr Diabetes Rev (2010) 0.84
ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery. Am J Cardiovasc Drugs (2010) 0.84
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both. Clin Ther (2004) 0.83
The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure. Eur J Heart Fail (2013) 0.83
Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease. Hypertension (2013) 0.83
"The lower the BP the better" paradigm in the elderly: vanished by VALISH? Hypertension (2010) 0.82
[Management of ST-elevation myocardial infarction in the Umbria region: results from the observational prospective Umbria-STEMI registry]. G Ital Cardiol (Rome) (2010) 0.82
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview. Expert Opin Drug Saf (2012) 0.82
Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement. Hypertension (2014) 0.81
Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. Eur Heart J (2009) 0.81
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach. Expert Opin Drug Saf (2014) 0.81
Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value. Hypertension (2005) 0.81